Recent Updates
Recently added Catalysts
PRPO

Precipio Announces Q3-2020 Shareholder Update Call Conference Call to be held on Thursday, November 19 th , 2020 at 5:00 PM EST NEW HAVEN, CT, (November 11 th , 2020) - Specialty cancer diagnostics company Precipio, Inc.

Key Takeaway: Q3-2020 Shareholder Update Call Call to be held on Thursday, November 19th, 2020 at 5:00 PM EST NEW HAVEN, CT, (November 11th, 2020) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2020 corporate update call on Thursday, November

Full Press Release Details

Q3-2020 Shareholder Update Call
Call to be held on Thursday, November 19th, 2020 at 5:00 PM EST
NEW HAVEN, CT, (November 11th,
2020) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:
PRPO), will be hosting its Q3-2020 corporate update call on Thursday, November
19th at 5:00 PM ET. The call will include updates on the company's current core businesses, as well as an update
on the company's COVID-19 testing initiative.
The conference call may be accessed
by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call.
Participants may also pre-register for the conference call at https://dpregister.com/sreg/10150005/dd310278c1 and
will receive a calendar invite and a direct dial-in number, bypassing the operator.
Listeners interested in submitting
questions in advance should email their questions to investors@precipiodx.com and
management will do its best to address those questions during the call.
A replay of the call will be available
approximately 24 hours after the call and may be accessed via the Investors page on Precipio's website, http://www.precipiodx.com/investors.html.
Precipio has built a platform designed
to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions
and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class
academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine and Harvard's
Dana-Farber Cancer Institute, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.
For more information, please visit www.precipiodx.com.
Forward-Looking Statements
This press release contains "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel
coronavirus (COVID-19) pandemic, and the related responses of the government, consumers, and the company, on our business, financial
condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise,
involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, growth,
costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations,
growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections.
Words such as "could," "may," "expects," "anticipates," "will," "targets,"
"goals," "projects," "intends," "plans," "believes," "seeks,"
"estimates," "predicts," and variations on such words, and similar expressions that reflect our current
views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking
statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could
differ materially from those discussed. Important factors that could affect performance and cause results to differ materially
from management's expectations, or could affect the company's ability to achieve its strategic goals, include the uncertainties
relating to the impact of COVID-19 on the company's business, operations and employees and the other factors that are described
in the sections entitled "Risk Factors" and "Management's Discussion and Analysis" in the company's
Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as updated from time to time in the company's Securities
and Exchange Commission filings.
The company's forward-looking statements
in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events
and speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.
Last updated: Nov 12, 2020